Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Understanding biomarkers of neurodegeneration: Novel approaches to detecting tau pathology.

Literature DB >> 25742457

Understanding biomarkers of neurodegeneration: Novel approaches to detecting tau pathology.

Casey N Cook¹, Melissa E Murray¹, Leonard Petrucelli¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2015 PMID： 25742457 DOI： 10.1038/nm.3809

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

14 in total

1. A protein factor essential for microtubule assembly.

Authors: M D Weingarten; A H Lockwood; S Y Hwo; M W Kirschner
Journal: Proc Natl Acad Sci U S A Date: 1975-05 Impact factor: 11.205

2. PET of brain amyloid and tau in mild cognitive impairment.

Authors: Gary W Small; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Susan Y Bookheimer; Karen J Miller; Helen Lavretsky; Alison C Burggren; Greg M Cole; Harry V Vinters; Paul M Thompson; S-C Huang; N Satyamurthy; Michael E Phelps; Jorge R Barrio
Journal: N Engl J Med Date: 2006-12-21 Impact factor: 91.245

Review 3. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors: J C Morris; J L Price
Journal: J Mol Neurosci Date: 2001-10 Impact factor: 3.444

4. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

Authors: David T Chien; Shadfar Bahri; A Katrin Szardenings; Joseph C Walsh; Fanrong Mu; Min-Ying Su; William R Shankle; Arkadij Elizarov; Hartmuth C Kolb
Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472

5. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo.

Authors: Marc I Diamond; David M Holtzman; Kiran Yanamandra; Najla Kfoury; Hong Jiang; Thomas E Mahan; Shengmei Ma; Susan E Maloney; David F Wozniak
Journal: Neuron Date: 2013-09-26 Impact factor: 17.173

6. Trans-cellular propagation of Tau aggregation by fibrillar species.

Authors: Najla Kfoury; Brandon B Holmes; Hong Jiang; David M Holtzman; Marc I Diamond
Journal: J Biol Chem Date: 2012-03-29 Impact factor: 5.157

7. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.

Authors: Michelle T Fodero-Tavoletti; Nobuyuki Okamura; Shozo Furumoto; Rachel S Mulligan; Andrea R Connor; Catriona A McLean; Diana Cao; Angela Rigopoulos; Glenn A Cartwright; Graeme O'Keefe; Sylvia Gong; Paul A Adlard; Kevin J Barnham; Christopher C Rowe; Colin L Masters; Yukitsuka Kudo; Roberto Cappai; Kazuhiko Yanai; Victor L Villemagne
Journal: Brain Date: 2011-03-24 Impact factor: 13.501

Review 5. Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.

Authors: Qingwei Ruan; Grazia D'Onofrio; Daniele Sancarlo; Antonio Greco; Zhuowei Yu
Journal: Mol Med Rep Date: 2016-08-09 Impact factor: 2.952

5 in total

Understanding biomarkers of neurodegeneration: Novel approaches to detecting tau pathology.

1. A protein factor essential for microtubule assembly.

2. PET of brain amyloid and tau in mild cognitive impairment.

Review 3. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

4. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

5. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo.

6. Trans-cellular propagation of Tau aggregation by fibrillar species.

7. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.

Review 8. Neuropathological stageing of Alzheimer-related changes.

9. Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

10. Dementia: a global health priority - highlights from an ADI and World Health Organization report.

Review 1. Amyloid positron emission tomography and cognitive reserve.

2. Neuroprotective Functions for the Histone Deacetylase SIRT6.

Review 3. Blood biomarkers for brain injury: What are we measuring?

Review 4. Towards Personalized Intervention for Alzheimer's Disease.

Review 5. Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.